^
    almost3years
    8/17 #TumorBoardTuesday #BRCA 👩🏽‍🏫Mini tweetorial 6👩🏻‍🏫 🎉@US_FDA Olaparib👍🏽for gBRCA1/2 mut MBC (Jan 2018) 🎉Talazoparib 👍🏽 for gBRCA1/2 mut MBC (Oct 2018) 📍No restrictions which line of tx 🧪BRACAnalysis CDx test 👍🏽 as @US_FDA companion diagnostic @drjenniferg ()
    BRCA Companion diagnostic • PARP Companion diagnostic • Companion diagnostic
    |
    BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • BRCA (Breast cancer early onset)
    |
    BRACAnalysis CDx™
    |
    Lynparza (olaparib) • Talzenna (talazoparib)
    4years
    Great talk by Alicia Morgans @CaPsurvivorship at #SUO21 regarding the importance of germline AND somatic genetic testing in ALL men with mCRPC!! Drop by the Myriad Genetics Booth if you have any questions. @MyriadMyRisk #BRACAnalysisCDx @ProlarisTest (@RobFinchCGC)
    BRACAnalysis CDx™ • Prolaris®
    almost6years
    ". @US_FDA Approves @myriadgenetics BRACAnalysis CDx for Lynparza in Metastatic #PancreaticCancer: https://t.co/KJPBMYmB6u" (@ClinicalOMICs)
    FDA event
    |
    BRACAnalysis CDx™
    |
    Lynparza (olaparib)
    7years
    ".@myriadgenetics’ BRACAnalysis CDX has received #FDA approval for @Pfizer’s Talzenna therapy #breastcancer #BRCA https://t.co/onuYIWg9CR" (@360DxNews)
    FDA event
    |
    BRACAnalysis CDx™
    |
    Talzenna (talazoparib)
    7years
    ". @US_FDA Approves @myriadgenetics’ BRACAnalysis CDx for Use with @pfizer’s Talzenna: https://t.co/9AMW3hfNWA" (@ClinicalOMICs)
    FDA event
    |
    BRACAnalysis CDx™
    |
    Talzenna (talazoparib)